Singapore boosts its medical technology R&D (research and development) drive:
This article was originally published in Clinica
Singapore hopes to boost local medtech research and development with the launch of a new scheme, the Medtech Concept Initiative. The Economic Development Board's biomedical sciences group (BMSG) has partnered with Nanyang Polytechnic (NP) to build upon the 2003 BMSG's proof-of-concept (POC) initiative. This encouraged projects that showed promise of developing into start-up businesses by providing them with research funding of up to S$300,000 (US$ 177,000). In addition to these funds, eligible projects under the new scheme will benefit from NP's existing infrastructure and resources.
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.